Related Experiment Video
Updated: Jun 12, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
A Case Series Examining the 1-year Follow-up Outcomes of Myocarditis Associated with COVID-19 Vaccination
Mohammed Thamer Ali1, Ammar Chapra1, Samah F A Mohamed2,3
1Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Insights
Myocarditis following COVID-19 mRNA vaccination is rare, affecting young males within a week of vaccination. Most patients show favorable short-term recovery with minimal long-term consequences, though extended follow-up is recommended.
Area of Science:
- Cardiology
- Vaccinology
- Public Health
Background:
- COVID-19 mRNA vaccines have been associated with rare cases of myocarditis.
- This condition primarily affects young males, typically presenting symptoms within one week post-vaccination.
Purpose of the Study:
- To evaluate the long-term outcomes of individuals diagnosed with myocarditis after receiving COVID-19 vaccination.
- To understand the potential long-term implications of vaccine-related myocarditis.
Main Methods:
- A case series analysis was conducted.
- Seventeen patients diagnosed with inflammatory myocarditis following COVID-19 mRNA vaccination were included.
Main Results:
- Symptom onset occurred 24-96 hours post-vaccination.
- Most patients experienced favorable short-term recovery with minimal long-term consequences.
- Cardiac magnetic resonance imaging (CMR) revealed preserved ejection fraction and absence or minimal fibrosis in most patients, with one case showing hypertrophic cardiomyopathy-like fibrosis.
Conclusions:
- While COVID-19 mRNA vaccine-related myocarditis appears to have a generally benign short-term course, prolonged clinical and CMR follow-up exceeding one year is essential.
- Extended monitoring is crucial for a comprehensive understanding of the condition's true nature and long-term implications.
- This approach will enhance the ongoing assessment of COVID-19 vaccination program safety and efficacy.
Background:
COVID-19 messenger RNA (mRNA) vaccine-related myocarditis, though rare, primarily affects young males and often presents its symptoms within the 1st week postvaccination.
Aims And Objectives:
To assess the long-term outcomes of individuals diagnosed with myocarditis following COVID-19 vaccination.
Materials And Methods:
We conducted a case series analysis involving 17 patients diagnosed with inflammatory myocarditis.
Results:
Symptoms in these patients typically appeared 24-96 h after receiving the COVID-19 mRNA vaccine. Fortunately, the prognosis for these patients is generally favorable, characterized by good short-term recovery and minimal long-term consequences. Follow-up cardiac magnetic resonance imaging (CMR) among our patients revealed alongside a preserved ejection fraction, the absence of fibrosis in 7 out of 13 (54%) patients with minimal residual fibrosis in 5 (38%) patients, whereas the remaining one patient demonstrated fibrosis consistent with hypertrophic cardiomyopathy.
Conclusion:
Despite the seemingly benign nature of COVID-19 mRNA vaccine-related myocarditis thus far, it is crucial to emphasize the necessity of prolonged clinical and CMR follow-up exceeding 1 year. Extended monitoring is essential to gain a deeper understanding of the true nature of this condition and its potential implications. This comprehensive approach will contribute significantly to ensuring the ongoing safety and efficacy of COVID-19 vaccination programs.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical features and Diagnostic Tests
Myocarditis IV: Nursing Management
Myocarditis I: Introduction
Endocarditis III: Medical Management
Pericarditis II: Clinical features and Diagnostic Tests